Table 3.

The KEGG Pathway Enrichment Analysis

ID	Description	GeneRatio	BgRatio	pvalue	p.Adjust	qvalue	GeneID	Count
hsa04210	Apoptosis	11/63	136/8073	6.03E-09	1.13E-06	6.98E-07	3709/332/2081/581/3725/1649/1509/27113/7185/1515/2353	11
hsa05418	Fluid shear stress and atherosclerosis	9/63	139/8073	1.10E-06	0.000103714	6.39E-05	3791/3162/4846/3320/3725/5563/653361/5881/2353	9
hsa04151	PI3K-Akt signaling pathway	13/63	354/8073	2.54E-06	0.000159237	9.81E-05	3791/4846/4233/1026/6696/54541/3655/3320/5563/3479/7058/2323/5522	13
hsa05210	Colorectal cancer	7/63	86/8073	4.15E-06	0.000195185	0.000120215	1026/332/581/3725/5881/27113/2353	7
hsa04915	Estrogen signaling pathway	8/63	138/8073	1.04E-05	0.000392422	0.000241693	3875/3709/4846/3320/3725/1509/9568/2353	8
hsa04115	p53 signaling pathway	6/63	73/8073	2.01E-05	0.000628788	0.000387272	1026/581/1111/3479/27113/7161	6
hsa05170	Human immunodeficiency virus 1 infection	9/63	212/8073	3.46E-05	0.000930382	0.000573024	3709/920/581/3725/684/1111/5881/130340/2353	9
hsa01522	Endocrine resistance	6/63	98/8073	0.000106638	0.002506002	0.00154345	1026/581/3725/1869/3479/2353	6
hsa04510	Focal adhesion	8/63	201/8073	0.000153644	0.002892839	0.001781704	3791/4233/6696/3655/3725/3479/5881/7058	8
hsa04932	Non-alcoholic fatty liver disease	7/63	150/8073	0.000153874	0.002892839	0.001781704	2081/581/3725/1649/3953/5563/2353	7
hsa04921	Oxytocin signaling pathway	7/63	154/8073	0.000181221	0.003097237	0.001907592	3709/952/4846/1026/3725/5563/2353	7
hsa05218	Melanoma	5/63	72/8073	0.000230606	0.003582729	0.002206608	4233/1026/581/1869/3479	5
hsa05161	Hepatitis B	7/63	162/8073	0.000247742	0.003582729	0.002206608	1026/3339/332/581/3725/1869/2353	7
hsa04071	Sphingolipid signaling pathway	6/63	119/8073	0.000309561	0.00415696	0.002560278	4846/581/1509/8877/5881/5522	6
hsa04140	Autophagy - animal	6/63	137/8073	0.000657484	0.007954181	0.004898991	8673/54541/2081/1509/5563/23604	6